GGrantIndex
Sort

50,496 grants matching lung cancer

Prostate Cancer Studies

$975,352
Ann Hsing · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

Mitogenesis Networks

$975,269
Forest M White · Massachusetts Institute Of Technology · U54 · FY2013 · CA

Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity

$975,215
Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2024 · DK

Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity

$975,215
Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2023 · DK

Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma

$974,959
Yen Tun Wang · Curebiotech, Inc. · R44 · FY2020 · CA

Novel Stem Cell Immunotherapy for MDR-Tuberculosis

$974,750
Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2021 · AI

Lead optimization of novel ML-IAP antagonists to treat lung cancer

$974,339
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA

Lead optimization of novel ML-IAP antagonists to treat lung cancer

$974,339
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA

A Phase I Study of Mistletoe Extract on PK, PD, and Safety of Gemcitabine in CA

$974,000
Patrick J Mansky · Complementary & Integrative Health · Z01 · FY2007 · AT

Reducing Cancer Health Disparities in Detroit

$973,764
Ann G Schwartz · Wayne State University · P20 · FY2023 · CA

Next Generation Smart Nanoparticles

$973,458
Jianghong Rao · Stanford University · U54 · FY2014 · CA

DIESEL PARTICLE EXPOSURE AND LUNG CANCER

$973,384
Brigham And Women'S Hospital · R01 · FY2001 · CA

Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging

$973,384
Stanton L Gerson · Case Western Reserve University · U54 · FY2024 · CA

Systemic regulation of metastasis

$973,323
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2023 · CA

MIT Center for Environmental Health Sciences

$973,168
Jacquin C Niles · Massachusetts Institute Of Technology · P30 · FY2019 · ES

Breast and Ovary Cancer Clinical Validation Center

$973,064
Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2012 · CA

Breast, Colorectal, and Ovary Cancer Clinical Validation Center

$972,870
Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2017 · CA

Genomics and Proteomics of Head and Neck Cancer

$972,669
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC

New Paradigms for Targeting Truncal Driver Mutations

$972,607
William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2018 · CA

Etiological Studies of Gastric Carcinoma

$972,592
Pelayo Correa · Vanderbilt University · P01 · FY2006 · CA

Regulation of Ras-Dependent Signal Transduction Pathways

$972,526
Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center

$972,480
Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2024 · CA

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

$972,261
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies

$972,086
Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Cancer Risk in Human Populations

$972,043
Mark Purdue · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA